Learn more →
Back to Expert Scholars
AI in Cancer Research / AI+癌症研究Vascular Imaging

David A. Bluemke

大卫·布鲁姆克

MD, PhD, FACR

🏢University of Wisconsin-Madison(威斯康星大学麦迪逊分校)🌐USA

Professor and Chair, Department of Radiology; Editor Emeritus, Radiology放射科教授兼主任;《放射学》名誉主编

150
h-index
1
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

David A. Bluemke, MD, PhD, FACR is a pioneering cardiovascular imaging researcher whose leadership of the Multi-Ethnic Study of Atherosclerosis (MESA) has transformed population-level cardiovascular research. As Chair of Radiology at UW-Madison and Editor Emeritus of Radiology, he shapes both research and publication standards. With over 101,000 citations and h-index 150+, he ranks among the most influential radiologists globally.

David A. Bluemke医学博士、哲学博士、FACR是一位开创性的心血管影像研究者,他领导的多民族动脉粥样硬化研究(MESA)改变了人群水平的心血管研究。作为威斯康星大学麦迪逊分校放射科主任和《放射学》名誉主编,他塑造了研究和出版标准。凭借超过101,000次引用和150+的h指数,他是全球最具影响力的放射科医生之一。

Share:

🧪Research Fields 研究领域

Cardiac MRI心脏MRI
MESA StudyMESA研究
Cardiovascular Imaging心血管影像
Imaging Biomarkers影像生物标志物

🎓Key Contributions 主要贡献

MESA Study Leadership

Principal Investigator of MESA MRI Study, defining cardiac structure/function reference values across diverse populations

CMR Biomarker Development

Established CMR-based biomarkers for cardiovascular risk prediction now used clinically worldwide

Representative Works 代表性著作

[1]

The relationship of left ventricular mass and geometry to incident cardiovascular events

Journal of the American College of Cardiology (2008)

Landmark MESA paper establishing LV mass-cardiovascular event relationships

🏆Awards & Recognition 奖项与荣誉

🏆Editor, Radiology (2011-2021)
🏆NIH Distinguished Investigator
🏆FACR

📄Data Sources 数据来源

Last updated: 2026-03-12 | All information from publicly available academic sources

关注 大卫·布鲁姆克 的研究动态

Follow David A. Bluemke's research updates

留下邮箱,当我们发布与 David A. Bluemke(University of Wisconsin-Madison)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment